跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEBARAT 1 MG/ML SOLUCION PARA PULVERIZACION NASAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TEBARAT 1 MG/ML SOLUCION PARA PULVERIZACION NASAL
Approved
STANDARD
TEBARAT 1 MG/ML SOLUCION PARA PULVERIZACION NASAL
Laboratorios Salvat S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 25, 2022
Approval ID
c8b0e5536ad09d7d
Company
Laboratorios Salvat S.A.
Type
Standard
Approval Details
Approval Id
c8b0e5536ad09d7d
Drug Cima Aemps Name
TEBARAT 1 MG/ML SOLUCION PARA PULVERIZACION NASAL
Register Number
88318
Holder Company Name
Laboratorios Salvat S.A.
Marketing Company Name
Laboratorios Salvat S.A.
Authorization Date
2022-11-25
Dosage Form
SOLUCION PARA PULVERIZACION NASAL
Dose
1 mg/ml
Route Of Administration
VÍA NASAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Salvat S.A.
Active Ingredients
AZELASTINA HIDROCLORURO
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 25, 2022
Approval ID
c8b0e5536ad09d7d
Type
Standard
Back to CIMA-AEMPS Approvals
